|Cat. No. :
|Product Overview :
||Recombinant Human IL-33 produced in E.coli is a single, non-glycosylated polypeptide chain containing 159 amino acids and having a molecular mass of 18 kDa.
||Human interleukin 33 (IL-33) is a cytokine of the IL-1 superfamily, which is also known as NF-HEV, nuclear factor (NF) in high endothelial venules" (HEVs) and DVS27, a protein that is upregulated in vasospastic cerebral arteries. IL-33, NF-HEV and DVS27 refer to the same protein that is expressed primarily by endothelial and smooth muscle cells in the vasculature and airway. IL-33 mediates its biological effects via IL-1 receptor ST 2, activates NF-kappaB and MAP kinases, and drives production of type 2 cytokines (e.g.IL-4, IL-5 and IL-13) from polarized Th2 cells, leading to severe pathological changes in mucosal organs. Human IL-33 consists of an N-terminal nuclear localization signal (NLS), a helix-turn-helix (HTH) motif, and a C-terminal region with structural homology to IL-1 family cytokines. The C-terminal fragment serves as a cytokine which can be generated by the cleavage of caspase-1 in vitro. IL-33 exhibits both nuclear and extracellular functions.
|Biological Activity :
||The ED50 of rhIL33 as determined by proliferation of D10.G4.1 mouse helper T cells costimulated with B71/Fc Chimera and antiCD3 was < 2ng/ml, corresponding to a Specific Activity of 5.0 x 105 IU/mg.
||Greater than 95% as determined by (a) Analysis by RP-HPLC; (b) Analysis by reducing and non-reducing SDS-PAGE Silver Stained gel.
|Amino-Acid Sequence :
||The sequence of the first five N-terminal amino acids was determined and was found to be Ser-Ile-Thr-Gly-Ile.
||Less than 0.1 ng/µg (1 IEU/µg) of rHuIL-33.
||The protein was lyophilized after extensive dialysis against 20 mM PB, pH 7.4, 1mM EDTA.
||It is recommended to quick spin followed by reconstitution of rHuIL-33 in PBS to a concentration no less than 100µg/ml, which can then be further diluted to other aqueous solutions.
||Lyophilized rHuIL-33 although stable at room temperature for 3 weeks, should be stored desiccated below -18°C. Upon reconstitution rHuIL-33 should be stored at 4°C between 2-7 days and for future use below -18°C. For long-term storage it is recommended to add a carrier protein (0.1% HSA or BSA). Please avoid freeze-thaw cycles.